DNA hypomethylation by fisetin preserves mitochondria functional genes and contributes to the protection of I/R rat heart
Authors:
- 25 October 2023
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (4) , 1-12
Abstract
Myocardial I/R can alter the expression of different sets of cardiac genes that negatively influence the I/R outcome via epigenetic modifications. Fisetin is known to be cardioprotective against I/R, but its underlying epigenetic mode of action is not known and is addressed in the present study. Male Wistar rats were subjected to I/R by using the Langendorff perfusion system. Fisetin (20 mg/kg; i.p.) was administered before I/R induction, followed by the measurement of cardiac injury, hemodynamics, physiological indices, the differential expression of genes that regulate DNA methylation, and the function of mitochondria were performed. Fisetin administered I/R rat heart significantly reduced the global DNA hypermethylation and infarct size with an improved physiological recovery, measured via RPP (81%) and LVDP (82%) from the I/R control. Additionally, we noted decreased expression of the DNMT1 gene by 35% and increased expression of the TET1, TET2, and TET3 genes in fisetin-treated I/R rat hearts. Molecular docking analysis data reveals that the fisetin inhibits DNMT1 at the substrate binding site with minimum binding energy (− 8.2 kcal/mol) compared to the DNMT1 inhibitor, 5-azacytidine. Moreover, fisetin-treated I/R heart reversed the expression of the I/R-linked declined expression of bioenergetics genes (MT-ND1, MT-ND2, MT-ND4, MT-Cyt B, MT-COX1, MT-COX2, MT-ATP6), mitochondrial fission gene (Fis1), replication control genes PGC-1α, POLG, and TFAM to near-normal level. Based on the above findings, we demonstrated that fisetin possesses the ability to modulate the expression of different mitochondrial genes via influencing the global DNA methylation in cardiac tissue, which contributes significantly to the improved contractile function and thereby renders cardioprotection against I/R.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (EMR/2017/000669)
This publication has 32 references indexed in Scilit:
- Overexpression of TFAM or Twinkle Increases mtDNA Copy Number and Facilitates Cardioprotection Associated with Limited Mitochondrial Oxidative StressPLOS ONE, 2015
- Association of mitochondrial DNA levels with frailty and all-cause mortalityJournal of Molecular Medicine, 2014
- Myocardial ischemia-reperfusion injury: a neglected therapeutic targetJournal of Clinical Investigation, 2013
- Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.2013
- Alterations in bioenergetics due to changes in mitochondrial DNA copy numberMethods, 2010
- DNA Methylation as a Biomarker for Cardiovascular Disease RiskPLOS ONE, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Mitochondria and Ischemia/Reperfusion InjuryAnnals of the New York Academy of Sciences, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscleJournal of Biological Chemistry, 1977